A retrospective cohort study of the impact of peripheral blood gamma- delta T cells to prognosis of nonmetastatic renal cell cancer after curative resection
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A retrospective cohort study of the impact of peripheral blood gamma- delta T cells to prognosis of nonmetastatic renal cell cancer after curative resection
Authors
Keywords
-
Journal
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-11-01
DOI
10.1016/j.urolonc.2023.10.001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
- (2022) Robert J. Motzer et al. Journal of the National Comprehensive Cancer Network
- European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update
- (2022) Börje Ljungberg et al. EUROPEAN UROLOGY
- Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2022) Thomas Powles et al. LANCET ONCOLOGY
- Baseline anemia predicts a poor prognosis in patients with non-small cell lung cancer with epidermal growth factor receptor mutations: a retrospective study
- (2022) Jingwen Wei et al. BMC Pulmonary Medicine
- CTCs-oriented adjuvant personalized cytostatic therapy non-metastatic breast cancer patients: continuous non-randomized prospective study and prospective randomized controlled study
- (2021) Ya A. Shliakhtunou BREAST CANCER RESEARCH AND TREATMENT
- Steps in metastasis: an updated review
- (2021) Jamal Majidpoor et al. MEDICAL ONCOLOGY
- Prognostic value of peripheral blood T lymphocyte subsets in clear cell renal cell carcinoma
- (2021) Yihong Zhou et al. Translational Andrology and Urology
- Preoperative anemia predicts poor prognosis in patients with endometrial cancer: A systematic review and meta-analysis
- (2021) Ahmed Abu-Zaid et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Adjuvant therapy in renal cell carcinoma: Current knowledges and future perspectives
- (2021) Mathieu Larroquette et al. CANCER TREATMENT REVIEWS
- Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I
- (2021) Steven C. Campbell et al. JOURNAL OF UROLOGY
- Risk models for recurrence and survival after kidney cancer: a systematic review
- (2021) Juliet A. Usher‐Smith et al. BJU INTERNATIONAL
- Functional Phenotypes of Human Vγ9Vδ2 T Cells in Lymphoid Stress Surveillance
- (2020) Oliver Nussbaumer et al. Cells
- Combined C-Reactive Protein and Novel Inflammatory Parameters as a Predictor in Cancer—What Can We Learn from the Hematological Experience?
- (2020) Øystein Bruserud et al. Cancers
- NK cells-directed therapies target circulating tumor cells and metastasis
- (2020) Hassan Dianat-Moghadam et al. CANCER LETTERS
- Preoperative Anemia or Low Hemoglobin Predicts Poor Prognosis in Gastric Cancer Patients: A Meta-Analysis
- (2019) Xuan-zhang Huang et al. DISEASE MARKERS
- γδ T cell responses: How many ligands will it take till we know?
- (2018) David Vermijlen et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab
- (2016) Kilian Wistuba-Hamprecht et al. EUROPEAN JOURNAL OF CANCER
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
- (2014) Arnoud J. Templeton et al. JNCI-Journal of the National Cancer Institute
- γδ T cells for cancer immunotherapy
- (2014) Jonathan PH Fisher et al. OncoImmunology
- Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma - results from a comprehensive multi-centre database (CORONA/SATURN-Project)
- (2013) Sabine D. Brookman-May et al. BJU INTERNATIONAL
- Long-term outcome of small, organ-confined renal cell carcinoma (RCC) is not always favourable
- (2013) Tetsuya Shindo et al. BJU INTERNATIONAL
- Validation of serum C-reactive protein (CRP) as an independent prognostic factor for disease-free survival in patients with localised renal cell carcinoma (RCC)
- (2013) Michela de Martino et al. BJU INTERNATIONAL
- Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consortium criteria
- (2013) Nils Kroeger et al. CANCER
- Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma
- (2011) Hirohito Kobayashi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Epidemiology of Renal Cell Cancer
- (2011) Eunyoung Cho et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Anemia in cancer
- (2010) M. Dicato et al. ANNALS OF ONCOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started